Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | TT-702 |
Synonyms | |
Therapy Description |
TT-702 is an antagonist of the A2B (ADORA2B) receptor that inhibits agonist-stimulated cAMP production, potentially leading to decreased tumor fibrosis and angiogenesis, enhanced antitumor immune response, and decreased tumor growth (Cancer Res 2021;81(13_Suppl):Abstract nr 55). |